Skip to main content
Top
Published in: BMC Cancer 1/2013

Open Access 01-12-2013 | Research article

Pleural cancer mortality in Spain: time-trends and updating of predictions up to 2020

Authors: Gonzalo López-Abente, Montserrat García-Gómez, Alfredo Menéndez-Navarro, Pablo Fernández-Navarro, Rebeca Ramis, Javier García-Pérez, Marta Cervantes, Eva Ferreras, María Jiménez-Muñoz, Roberto Pastor-Barriuso

Published in: BMC Cancer | Issue 1/2013

Login to get access

Abstract

Background

A total of 2,514,346 metric tons (Mt) of asbestos were imported into Spain from 1906 until the ban on asbestos in 2002. Our objective was to study pleural cancer mortality trends as an indicator of mesothelioma mortality and update mortality predictions for the periods 2011–2015 and 2016–2020 in Spain.

Methods

Log-linear Poisson models were fitted to study the effect of age, period of death and birth cohort (APC) on mortality trends. Change points in cohort- and period-effect curvatures were assessed using segmented regression. Fractional power-link APC models were used to predict mortality until 2020. In addition, an alternative model based on national asbestos consumption figures was also used to perform long-term predictions.

Results

Pleural cancer deaths increased across the study period, rising from 491 in 1976–1980 to 1,249 in 2006–2010. Predictions for the five-year period 2016–2020 indicated a total of 1,319 pleural cancer deaths (264 deaths/year). Forecasts up to 2020 indicated that this increase would continue, though the age-adjusted rates showed a levelling-off in male mortality from 2001 to 2005, corresponding to the lower risk in post-1960 generations. Among women, rates were lower and the mortality trend was also different, indicating that occupational exposure was possibly the single factor having most influence on pleural cancer mortality.

Conclusion

The cancer mortality-related consequences of human exposure to asbestos are set to persist and remain in evidence until the last surviving members of the exposed cohorts have disappeared. It can thus be assumed that occupationally-related deaths due to pleural mesothelioma will continue to occur in Spain until at least 2040.
Appendix
Available only for authorised users
Literature
1.
go back to reference Micheli A, Capocaccia R, Martinez C, Mugno E, Coebergh JW, Baili P, Verdecchia A, Berrino F, Coleman M: Cancer control in Europe: a proposed set of European cancer health indicators. Eur J Public Health. 2003, 13: 116-118.CrossRefPubMed Micheli A, Capocaccia R, Martinez C, Mugno E, Coebergh JW, Baili P, Verdecchia A, Berrino F, Coleman M: Cancer control in Europe: a proposed set of European cancer health indicators. Eur J Public Health. 2003, 13: 116-118.CrossRefPubMed
2.
go back to reference Segura O, Burdorf A, Looman C: Update of predictions of mortality from pleural mesothelioma in the Netherlands. Occup Environ Med. 2003, 60: 50-55. 10.1136/oem.60.1.50.CrossRefPubMedPubMedCentral Segura O, Burdorf A, Looman C: Update of predictions of mortality from pleural mesothelioma in the Netherlands. Occup Environ Med. 2003, 60: 50-55. 10.1136/oem.60.1.50.CrossRefPubMedPubMedCentral
3.
go back to reference Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R: EUROCARE-4: Survival of cancer patients diagnosed in 1995–1999: results and commentary. Eur J Cancer. 2009, 45: 931-991. 10.1016/j.ejca.2008.11.018.CrossRefPubMed Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R: EUROCARE-4: Survival of cancer patients diagnosed in 1995–1999: results and commentary. Eur J Cancer. 2009, 45: 931-991. 10.1016/j.ejca.2008.11.018.CrossRefPubMed
4.
go back to reference IARC: Overall evaluations of carcinogenicity: an updating of IARC monographs volumes 1 to 42. 1987, Lyon: IARC: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7 IARC: Overall evaluations of carcinogenicity: an updating of IARC monographs volumes 1 to 42. 1987, Lyon: IARC: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7
5.
go back to reference IARC: A review of human carcinogens: arsenic, metals, fibres, and dusts. 2012, Lyon: IARC: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol 100C IARC: A review of human carcinogens: arsenic, metals, fibres, and dusts. 2012, Lyon: IARC: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol 100C
6.
go back to reference Agudo A, González CA, Bleda MJ, Ramírez J, Hernández S, López F, Calleja A, Panadès R, Turuguet D, Escolar A, Beltrán M, González-Moya JE: Occupation and risk of malignant pleural mesothelioma: a case–control study in Spain. Am J Ind Med. 2000, 37: 159-168. 10.1002/(SICI)1097-0274(200002)37:2<159::AID-AJIM1>3.0.CO;2-0.CrossRefPubMed Agudo A, González CA, Bleda MJ, Ramírez J, Hernández S, López F, Calleja A, Panadès R, Turuguet D, Escolar A, Beltrán M, González-Moya JE: Occupation and risk of malignant pleural mesothelioma: a case–control study in Spain. Am J Ind Med. 2000, 37: 159-168. 10.1002/(SICI)1097-0274(200002)37:2<159::AID-AJIM1>3.0.CO;2-0.CrossRefPubMed
7.
go back to reference Calleja i Vila A, Hernández Carrascosa S: Amiant en edificis i instal · lacions Què fer?. 2001, Barcelona: Generalitat de Catalunya, Departament de Treball Calleja i Vila A, Hernández Carrascosa S: Amiant en edificis i instal · lacions Què fer?. 2001, Barcelona: Generalitat de Catalunya, Departament de Treball
8.
go back to reference Virta R: Worldwide asbestos supply and consumption trends from 1900 through 2003. 2006, U.S. Geological Survey: Reston, Virginia Virta R: Worldwide asbestos supply and consumption trends from 1900 through 2003. 2006, U.S. Geological Survey: Reston, Virginia
9.
go back to reference Marinaccio A, Montanaro F, Mastrantonio M, Uccelli R, Altavista P, Nesti M, Costantini AS, Gorini G: Predictions of mortality from pleural mesothelioma in Italy: a model based on asbestos consumption figures supports results from age-period-cohort models. Int J Cancer. 2005, 115: 142-147. 10.1002/ijc.20820.CrossRefPubMed Marinaccio A, Montanaro F, Mastrantonio M, Uccelli R, Altavista P, Nesti M, Costantini AS, Gorini G: Predictions of mortality from pleural mesothelioma in Italy: a model based on asbestos consumption figures supports results from age-period-cohort models. Int J Cancer. 2005, 115: 142-147. 10.1002/ijc.20820.CrossRefPubMed
10.
go back to reference López-Areal L: Observaciones clínicas y resumen bibliográfico de los riesgos del amianto. Med Segur Trab. 1971, 19: 21-40. López-Areal L: Observaciones clínicas y resumen bibliográfico de los riesgos del amianto. Med Segur Trab. 1971, 19: 21-40.
11.
go back to reference INHST: Estudio de la incidencia y evaluación de la población laboral expuesta a amianto en la industria española. 1992, Madrid: Instituto Nacional de Higiene y Seguridad en el Trabajo INHST: Estudio de la incidencia y evaluación de la población laboral expuesta a amianto en la industria española. 1992, Madrid: Instituto Nacional de Higiene y Seguridad en el Trabajo
12.
go back to reference Kogevinas M, Maqueda J, De La Orden V, Fernández F, Kauppinen T, Benavides FG: Exposición a carcinógenos laborales en España: aplicación de la base de datos CAREX. Arch Prev Riesgos Labor. 2000, 3: 153-159. Kogevinas M, Maqueda J, De La Orden V, Fernández F, Kauppinen T, Benavides FG: Exposición a carcinógenos laborales en España: aplicación de la base de datos CAREX. Arch Prev Riesgos Labor. 2000, 3: 153-159.
13.
go back to reference García-Gómez MG, Castañeda R, López VG, Vidal MM, Villanueva V, Espinosa ME: Evaluation of the national health surveillance program of workers previously exposed to asbestos in Spain (2008). Gac Sanit. 2012, 26: 45-50. 10.1016/j.gaceta.2011.06.012.CrossRef García-Gómez MG, Castañeda R, López VG, Vidal MM, Villanueva V, Espinosa ME: Evaluation of the national health surveillance program of workers previously exposed to asbestos in Spain (2008). Gac Sanit. 2012, 26: 45-50. 10.1016/j.gaceta.2011.06.012.CrossRef
14.
15.
go back to reference Banaei A, Auvert B, Goldberg M, Gueguen A, Luce D, Goldberg S: Future trends in mortality of French men from mesothelioma. Occup Environ Med. 2000, 57: 488-494. 10.1136/oem.57.7.488.CrossRefPubMedPubMedCentral Banaei A, Auvert B, Goldberg M, Gueguen A, Luce D, Goldberg S: Future trends in mortality of French men from mesothelioma. Occup Environ Med. 2000, 57: 488-494. 10.1136/oem.57.7.488.CrossRefPubMedPubMedCentral
16.
go back to reference Hodgson JT, McElvenny DM, Darnton AJ, Price MJ, Peto J: The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Br J Cancer. 2005, 92: 587-593.PubMedPubMedCentral Hodgson JT, McElvenny DM, Darnton AJ, Price MJ, Peto J: The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Br J Cancer. 2005, 92: 587-593.PubMedPubMedCentral
17.
go back to reference Pitarque S, Clèries R, Martínez JM, López-Abente G, Kogevinas M, Benavides FG: Mesothelioma mortality in men: trends during 1977–2001 and projections for 2002–2016 in Spain. Occup Environ Med. 2008, 65: 279-282. 10.1136/oem.2007.034769.CrossRefPubMed Pitarque S, Clèries R, Martínez JM, López-Abente G, Kogevinas M, Benavides FG: Mesothelioma mortality in men: trends during 1977–2001 and projections for 2002–2016 in Spain. Occup Environ Med. 2008, 65: 279-282. 10.1136/oem.2007.034769.CrossRefPubMed
18.
go back to reference Holford TR: Understanding the effects of age, period, and cohort on incidence and mortality rates. Annu Rev Public Health. 1991, 12: 425-457. 10.1146/annurev.pu.12.050191.002233.CrossRefPubMed Holford TR: Understanding the effects of age, period, and cohort on incidence and mortality rates. Annu Rev Public Health. 1991, 12: 425-457. 10.1146/annurev.pu.12.050191.002233.CrossRefPubMed
19.
go back to reference Breslow NE: Extra-Poisson variation in log-linear models. Appl Stat. 1984, 33: 38-44. 10.2307/2347661.CrossRef Breslow NE: Extra-Poisson variation in log-linear models. Appl Stat. 1984, 33: 38-44. 10.2307/2347661.CrossRef
20.
go back to reference R Development Core Team: R: A language and environment for statistical computing. 2005, Vienna, Austria: R Foundation for Statistical Computing R Development Core Team: R: A language and environment for statistical computing. 2005, Vienna, Austria: R Foundation for Statistical Computing
21.
go back to reference Muggeo VMR: Estimating regression models with unknown break-points. Stat Med. 2003, 22: 3055-3071. 10.1002/sim.1545.CrossRefPubMed Muggeo VMR: Estimating regression models with unknown break-points. Stat Med. 2003, 22: 3055-3071. 10.1002/sim.1545.CrossRefPubMed
22.
go back to reference Møller B, Fekjaer H, Hakulinen T, Sigvaldason H, Storm HH, Talbäck M, Haldorsen T: Prediction of cancer incidence in the Nordic countries: empirical comparison of different approaches. Stat Med. 2003, 22: 2751-2766. 10.1002/sim.1481.CrossRefPubMed Møller B, Fekjaer H, Hakulinen T, Sigvaldason H, Storm HH, Talbäck M, Haldorsen T: Prediction of cancer incidence in the Nordic countries: empirical comparison of different approaches. Stat Med. 2003, 22: 2751-2766. 10.1002/sim.1481.CrossRefPubMed
23.
go back to reference Solà Niubó C, Perdigó Solà M, Casanovas X: Prospección sobre la presencia de amianto o de materiales que lo contengan en edificios. 2001, Fundación para la Prevención de Riesgos Laborales: Barcelona Solà Niubó C, Perdigó Solà M, Casanovas X: Prospección sobre la presencia de amianto o de materiales que lo contengan en edificios. 2001, Fundación para la Prevención de Riesgos Laborales: Barcelona
24.
go back to reference Hastie T, Tibshirani R: Generalized additive models. 1990, New York: Chapman & Hall/CRC Hastie T, Tibshirani R: Generalized additive models. 1990, New York: Chapman & Hall/CRC
25.
go back to reference McCullagh P, Nelder J: Generalized Linear Models. 1989, London, UK: Chapman & Hall, 2CrossRef McCullagh P, Nelder J: Generalized Linear Models. 1989, London, UK: Chapman & Hall, 2CrossRef
26.
go back to reference Myojin T, Azuma K, Okumura J, Uchiyama I: Future trends of mesothelioma mortality in Japan based on a risk function. Ind Health. 2012, 50: 197-204. 10.2486/indhealth.MS1184.CrossRefPubMed Myojin T, Azuma K, Okumura J, Uchiyama I: Future trends of mesothelioma mortality in Japan based on a risk function. Ind Health. 2012, 50: 197-204. 10.2486/indhealth.MS1184.CrossRefPubMed
27.
go back to reference Selikoff IJ, Churg J, Hammond EC: Relation between exposure to asbestos and mesothelioma. N Engl J Med. 1965, 272: 560-565. 10.1056/NEJM196503182721104.CrossRefPubMed Selikoff IJ, Churg J, Hammond EC: Relation between exposure to asbestos and mesothelioma. N Engl J Med. 1965, 272: 560-565. 10.1056/NEJM196503182721104.CrossRefPubMed
28.
go back to reference Iwatsubo Y, Matrat M, Michel E, Boutin C, Galateau-Salle F, Jougla E, Bignon J, Pairon JC, Brochard P: Estimation of the incidence of pleural mesothelioma according to death certificates in France. Am J Ind Med. 2002, 42: 188-199. 10.1002/ajim.10098.CrossRefPubMed Iwatsubo Y, Matrat M, Michel E, Boutin C, Galateau-Salle F, Jougla E, Bignon J, Pairon JC, Brochard P: Estimation of the incidence of pleural mesothelioma according to death certificates in France. Am J Ind Med. 2002, 42: 188-199. 10.1002/ajim.10098.CrossRefPubMed
29.
go back to reference Menéndez-Navarro A: La literatura médica española sobre los riesgos del amianto durante el franquismo. Asclepio Revista de Historia de la Medicina y de la Ciencia. 2012, 64: 7-36. Menéndez-Navarro A: La literatura médica española sobre los riesgos del amianto durante el franquismo. Asclepio Revista de Historia de la Medicina y de la Ciencia. 2012, 64: 7-36.
30.
go back to reference Delgermaa V, Takahashi K, Park E-K, Le GV, Hara T, Sorahan T: Global mesothelioma deaths reported to the world health organization between 1994 and 2008. Bull World Health Organ. 2011, 89: 716-724. 10.2471/BLT.11.086678. 724A–724CCrossRefPubMedPubMedCentral Delgermaa V, Takahashi K, Park E-K, Le GV, Hara T, Sorahan T: Global mesothelioma deaths reported to the world health organization between 1994 and 2008. Bull World Health Organ. 2011, 89: 716-724. 10.2471/BLT.11.086678. 724A–724CCrossRefPubMedPubMedCentral
31.
go back to reference Ulvestad B, Kjaerheim K, Møller B, Andersen A: Incidence trends of mesothelioma in Norway, 1965–1999. Int J Cancer. 2003, 107: 94-98. 10.1002/ijc.11357.CrossRefPubMed Ulvestad B, Kjaerheim K, Møller B, Andersen A: Incidence trends of mesothelioma in Norway, 1965–1999. Int J Cancer. 2003, 107: 94-98. 10.1002/ijc.11357.CrossRefPubMed
32.
go back to reference Ministerio de Trabajo y Seguridad Social: Orden de 31 de octubre de 1984 por la que se aprueba el Reglamento sobre Trabajos con Riesgo de Amianto. 1984, BOE Ministerio de Trabajo y Seguridad Social: Orden de 31 de octubre de 1984 por la que se aprueba el Reglamento sobre Trabajos con Riesgo de Amianto. 1984, BOE
33.
go back to reference Ministerio de la Presidencia: Orden de 7 de diciembre de 2001 por la que se modifica el anexo I del Real Decreto 1406/1989, de 10 de noviembre, por el que se imponen limitaciones a la comercialización y al uso de ciertas sustancias y preparados peligrosos. 2001, BOE Ministerio de la Presidencia: Orden de 7 de diciembre de 2001 por la que se modifica el anexo I del Real Decreto 1406/1989, de 10 de noviembre, por el que se imponen limitaciones a la comercialización y al uso de ciertas sustancias y preparados peligrosos. 2001, BOE
34.
go back to reference Ministerio de la Presidencia: REAL DECRETO 396/2006, de 31 de marzo, por el que se establecen las disposiciones mínimas de seguridad y salud aplicables a los trabajos con riesgo de exposición al amianto. 2006, BOE Ministerio de la Presidencia: REAL DECRETO 396/2006, de 31 de marzo, por el que se establecen las disposiciones mínimas de seguridad y salud aplicables a los trabajos con riesgo de exposición al amianto. 2006, BOE
35.
go back to reference Møller B, Fekjaer H, Hakulinen T, Tryggvadóttir L, Storm HH, Talbäck M, Haldorsen T: Prediction of cancer incidence in the Nordic countries up to the year 2020. Eur J Cancer Prev. 2002, 11 (Suppl 1): S1-96.PubMed Møller B, Fekjaer H, Hakulinen T, Tryggvadóttir L, Storm HH, Talbäck M, Haldorsen T: Prediction of cancer incidence in the Nordic countries up to the year 2020. Eur J Cancer Prev. 2002, 11 (Suppl 1): S1-96.PubMed
36.
go back to reference Møller H, Fairley L, Coupland V, Okello C, Green M, Forman D, Møller B, Bray F: The future burden of cancer in England: incidence and numbers of new patients in 2020. Br J Cancer. 2007, 96: 1484-1488. 10.1038/sj.bjc.6603746.CrossRefPubMedPubMedCentral Møller H, Fairley L, Coupland V, Okello C, Green M, Forman D, Møller B, Bray F: The future burden of cancer in England: incidence and numbers of new patients in 2020. Br J Cancer. 2007, 96: 1484-1488. 10.1038/sj.bjc.6603746.CrossRefPubMedPubMedCentral
37.
go back to reference Mistry M, Parkin DM, Ahmad AS, Sasieni P: Cancer incidence in the United Kingdom: projections to the year 2030. Br J Cancer. 2011, 105: 1795-1803. 10.1038/bjc.2011.430.CrossRefPubMedPubMedCentral Mistry M, Parkin DM, Ahmad AS, Sasieni P: Cancer incidence in the United Kingdom: projections to the year 2030. Br J Cancer. 2011, 105: 1795-1803. 10.1038/bjc.2011.430.CrossRefPubMedPubMedCentral
38.
go back to reference Cancer Projections Network (C-Projections): Long-term projection methods: comparison of age-period- cohort model-based approaches. 2010, Alberta: Alberta Health Services Cancer Projections Network (C-Projections): Long-term projection methods: comparison of age-period- cohort model-based approaches. 2010, Alberta: Alberta Health Services
Metadata
Title
Pleural cancer mortality in Spain: time-trends and updating of predictions up to 2020
Authors
Gonzalo López-Abente
Montserrat García-Gómez
Alfredo Menéndez-Navarro
Pablo Fernández-Navarro
Rebeca Ramis
Javier García-Pérez
Marta Cervantes
Eva Ferreras
María Jiménez-Muñoz
Roberto Pastor-Barriuso
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2013
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-13-528

Other articles of this Issue 1/2013

BMC Cancer 1/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine